SE385695B - Nytt forfarande for framstellning av n-(1-etyl-alfa-pyrrolidylmetyl-)-2-metoxi-5-sulfoamidobensamid med terapeutiska egenskaper - Google Patents

Nytt forfarande for framstellning av n-(1-etyl-alfa-pyrrolidylmetyl-)-2-metoxi-5-sulfoamidobensamid med terapeutiska egenskaper

Info

Publication number
SE385695B
SE385695B SE7211723A SE1172372A SE385695B SE 385695 B SE385695 B SE 385695B SE 7211723 A SE7211723 A SE 7211723A SE 1172372 A SE1172372 A SE 1172372A SE 385695 B SE385695 B SE 385695B
Authority
SE
Sweden
Prior art keywords
sulfoamidobensamide
pyrrolidylmethyl
alfa
methoxy
ethyl
Prior art date
Application number
SE7211723A
Other languages
English (en)
Swedish (sv)
Inventor
E Denzler
Original Assignee
Fratmann Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fratmann Ag filed Critical Fratmann Ag
Publication of SE385695B publication Critical patent/SE385695B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C07D207/09Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/572Five-membered rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Electrical Discharge Machining, Electrochemical Machining, And Combined Machining (AREA)
  • Superconductors And Manufacturing Methods Therefor (AREA)
SE7211723A 1972-06-13 1972-09-12 Nytt forfarande for framstellning av n-(1-etyl-alfa-pyrrolidylmetyl-)-2-metoxi-5-sulfoamidobensamid med terapeutiska egenskaper SE385695B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH881372A CH562790A5 (no) 1972-06-13 1972-06-13

Publications (1)

Publication Number Publication Date
SE385695B true SE385695B (sv) 1976-07-19

Family

ID=4345021

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7211723A SE385695B (sv) 1972-06-13 1972-09-12 Nytt forfarande for framstellning av n-(1-etyl-alfa-pyrrolidylmetyl-)-2-metoxi-5-sulfoamidobensamid med terapeutiska egenskaper

Country Status (31)

Country Link
JP (1) JPS565733B2 (no)
AR (1) AR193288A1 (no)
AT (1) AT316536B (no)
AU (1) AU464143B2 (no)
BE (1) BE787180A (no)
BG (1) BG20575A3 (no)
CA (1) CA976554A (no)
CH (1) CH562790A5 (no)
CS (1) CS181712B2 (no)
DD (1) DD100249A5 (no)
DE (1) DE2246799A1 (no)
EG (1) EG10796A (no)
ES (1) ES407141A1 (no)
FI (1) FI59243C (no)
FR (1) FR2187782B1 (no)
GB (1) GB1345494A (no)
HU (1) HU165916B (no)
IE (1) IE36719B1 (no)
IL (1) IL40503A (no)
IT (1) IT1034031B (no)
LU (1) LU65860A1 (no)
MC (1) MC938A1 (no)
NL (1) NL7213128A (no)
NO (1) NO140347C (no)
OA (1) OA04167A (no)
PL (1) PL83580B1 (no)
RO (1) RO60562A (no)
SE (1) SE385695B (no)
YU (1) YU35119B (no)
ZA (1) ZA726084B (no)
ZM (1) ZM15172A1 (no)

Also Published As

Publication number Publication date
CH562790A5 (no) 1975-06-13
AU464143B2 (en) 1975-08-14
GB1345494A (en) 1974-01-30
AT316536B (de) 1974-07-10
FI59243B (fi) 1981-03-31
EG10796A (en) 1976-06-30
BE787180A (fr) 1973-02-05
YU242172A (en) 1979-12-31
ZM15172A1 (en) 1973-06-21
IL40503A0 (en) 1972-12-29
ZA726084B (en) 1973-05-30
HU165916B (no) 1974-12-28
NO140347C (no) 1979-08-15
RO60562A (no) 1976-09-15
NL7213128A (no) 1973-12-17
IT1034031B (it) 1979-09-10
PL83580B1 (no) 1975-12-31
JPS565733B2 (no) 1981-02-06
LU65860A1 (no) 1974-02-12
FI59243C (fi) 1981-07-10
YU35119B (en) 1980-09-25
FR2187782A1 (no) 1974-01-18
BG20575A3 (bg) 1975-12-05
DD100249A5 (no) 1973-09-12
ES407141A1 (es) 1975-11-01
JPS4985065A (no) 1974-08-15
AU4641672A (en) 1974-03-14
AR193288A1 (es) 1973-04-11
DE2246799A1 (de) 1974-01-10
CA976554A (en) 1975-10-21
IE36719B1 (en) 1977-02-02
OA04167A (fr) 1979-12-15
NO140347B (no) 1979-05-07
IL40503A (en) 1975-07-28
IE36719L (en) 1973-12-13
FR2187782B1 (no) 1976-01-23
CS181712B2 (en) 1978-03-31
MC938A1 (fr) 1973-08-10

Similar Documents

Publication Publication Date Title
SE407579B (sv) Forfarande for framstellning av n-fosfonometylglycin
SE398877B (sv) Forfarande for framstellning av 14-hydroxi-morfinanderivat
SE405599B (sv) Forfarande for framstellning av pyridazinoner med terapeutisk verkan
NO140731C (no) Fremgangsmaate for fremstilling av dimetyleter
SE411755B (sv) Forfarande for framstellning av n-substituerade 1-aminometylindaner
SE382053B (sv) Forfarande for framstellning av bifenylylalkanoylaminopyridiner
SE383151B (sv) Forfarande for framstellning av 1-hydroxi-2-pyridoner
SE395892B (sv) Forfarande for framstellning av piperidyl-bensimidazoliner med terapeutisk verkan
SE402102B (sv) Forfarande for framstellning av 4-amino-n-(1-cyklohexyl-3-pyrrolidinyl)-n-alkyl-bensamider, med verdefulla terapeutiska egenskaper
SE402456B (sv) Analogiforfarande for framstellning av fenyletylaminderivat med anorexigen aktivitet
SE392615B (sv) Forfarande for framstellning av 2-nitro-5-imidazolaldehydderivat
SE385696B (sv) Nytt forfarande for framstellning av n-(1-etyl-alfa-pyrrolidylmetyl)-2-metoxi-5-sulfamidobensamid med terapeutiska egenskaper
SE380272B (sv) Forfarande for framstellning av n-fosfonmetylglycin
SE393111B (sv) Forfarande for framstellning av d-2-halogen-6-metyl-8-substituerad - ergolin
SE412756B (sv) Alternativa forfarande for framstellning av 2-(aminofenylimino)-3-aza-1-tia-cykloalkaner
SE385005B (sv) Forfarande for framstellning av substituerade pyrrolidinmetanoler med terapeutisk verkan
SE384686B (sv) Forfarande for framstellning av linkomycinderivat
SE392722B (sv) Forfarande for framstellning av oxazolidinderivat med terapeutisk verkan
FI56830B (fi) Foerfarande foer framstaellning av asparaginylgrupper innehaollande biologiskt aktiva polypeptider
SE415355B (sv) Forfarande for framstellning av fosfonotioureider
SE393808B (sv) Forfarande for framstellning av isomaltit
SE410732B (sv) Analogiforfarande for framstellning av anilidderivat med terapeutisk verkan
SE380805B (sv) Forfarande for framstellning av oxazoler
SE391717B (sv) Forfarande for framstellning av 4-aryl-5-aminoalkyl-4-oxazolin-2-oner
SE383738B (sv) Forfarande for framstellning av sulfamoyl-bensensulfonamider med terapeutiska egenskaper